Tracking when private companies are nearing a sale, recap, or financing event has always been a guessing game. With thousands of sponsor-backed firms spread across sectors and geographies, most deal teams are forced to react after the market moves.
Investors, bankers, and service providers struggle to know which private companies are gearing up for a transaction or capital raise. Signals are scattered, opaque, and nearly impossible to track across thousands of PE- and VC-backed businesses.
Dakota centralizes those signals (holding periods, funding rounds, platform acquisition dates, ownership changes, and exit timing patterns) into one predictive transaction-readiness tool. Instead of waiting for headlines, users can see which companies are showing the strongest likelihood of pursuing a sale, recapitalization, or new financing before the market knows.
Below is today’s list of five PE- or VC-backed companies that, based on their hold period, financing stage, and last transaction date, appear to be credible candidates for a sale or next-round raise.
Nothing is guaranteed, but these companies fall squarely within the timing windows where sponsors typically look to generate liquidity or secure additional capital.
Sourced from Dakota Sponsor Backed Companies.
1. Inductive Bio
Inductive Bio is a biotechnology company specializing in accelerating small molecule drug discovery by addressing ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) challenges. Their platform integrates machine learning models, a comprehensive data consortium, and generative chemistry to optimize compound development, enabling faster and more efficient therapeutic advancements.
- Sector: Biotechnology / AI Drug Discovery
- Last known transaction date: Venture Series A, $25M, May 2025
- Why timing suggests a near-term transaction: Inductive Bio’s $25M Series A in May 2025 positions the company approximately 12–18 months from its last raise, aligning with typical Series A-to-B timing. With a differentiated data consortium model, backing from leading investors (Obvious Ventures, a16z Bio + Health, Lux Capital), and growing demand for AI-driven drug discovery solutions, the company is entering a scaling phase where follow-on capital is likely to support platform expansion, additional partnerships, and commercialization of its Compass platform.
View all private company data in Dakota Marketplace.
2. Symbiotic
Symbiotic is a blockchain protocol that provides a marketplace for shared economic security across decentralized networks. Its framework enables networks to source security from staked assets through a modular and permissionless architecture.
- Sector: Industrials
- Last known transaction date: Venture Series A, $29M, April 2025
- Why timing suggests a near-term transaction: Symbiotic’s $29M Series A announced in April 2025 places the company roughly 12–18 months removed from its most recent financing by mid to late 2026, aligning with the typical timing for Series A platforms preparing for their next growth round. As customer adoption, operational scale, and strategic partnerships expand, the company is likely to evaluate follow-on capital, strategic investment, or acquisition interest.
View all private company data in Dakota Marketplace.
3. CueZen
CueZen is a health technology company specializing in AI-driven personalization solutions aimed at enhancing health outcomes through behavior change at a national scale. Founded by Ankur Teredesai, Sunil Shinde, and Aloysius Lim, the company is headquartered in the United States and operates globally, delivering personalized health programs to over 5 million individuals across three continents. CueZen's core product is its AI-powered personalization engine, NudgeStream™, which integrates data from device sensors, self-reported outcomes, and clinical records to provide personalized health coaching.
- Sector: Digital Health / AI Healthcare
- Last known funding round: Seed, $5M, May 2025
- Why timing suggests a near-term transaction: CueZen’s $5M seed round in May 2025 positions the company within the typical 12–18 month window for a Series A raise. With backing from Point72 Ventures and a focus on enterprise health partnerships, the company is likely to pursue follow-on capital as it scales customer acquisition, expands platform capabilities, and deepens integrations across healthcare ecosystems.
View all private company data in Dakota Marketplace.
4. Gorgie
Gorgie is a beverage company that produces energy drinks made with green tea–derived caffeine and functional ingredients. Its products are positioned as better-for-you alternatives, combining energy support with wellness-focused formulations.
- Sector: Consumer Staples
- Last known funding round: Seed A Venture, $24.5M, April 2025
- Why timing suggests a near-term transaction: Gorgie’s $24.5M seed round announced in April 2025 places the company approximately 12–18 months removed from its initial financing by mid to late 2026, aligning with the typical window when seed-stage companies begin preparing for their next raise. Given the size of the round and early brand momentum, the company is likely to evaluate follow-on capital, strategic partnerships, or early acquisition interest as distribution and customer traction scale.
View all private company data in Dakota Marketplace.
5. Wonderskin
Wonderskin is a beauty brand specializing in makeup and skincare products, including lip stains, eyeliners, and skincare solutions. Founded in 2020 and headquartered in Fair Lawn, New Jersey, the company is known for its Wonder Blading technology, which offers transfer-proof and waterproof lip color. Wonderskin focuses on creating products that meet the needs of beauty consumers while ensuring skin-friendly formulas.
- Sector: Consumer / Beauty & Personal Care
- Last known funding round: Series A, $50M, May 2025
- Why timing suggests a near-term transaction: Wonderskin’s $50M Series A in May 2025, led by Insight Partners, positions the company within the typical 12–18 month window for a follow-on growth round. With strong consumer traction driven by viral products, expanding retail distribution, and continued investment in product innovation, the company is likely to pursue additional capital to scale internationally, broaden its product portfolio, and deepen its position as a category-leading beauty brand.
View all private company data in Dakota Marketplace.
Use Dakota’s Sponsor Backed Company Intelligence to Spot Likely Exits Before the Market Does
Dakota’s private company data gives you a real-time view into thousands of sponsor-backed companies, including platform acquisition dates, funding rounds, parent sponsors, add-on activity, and sector categorization.
Instead of guessing where companies are in their lifecycle, you can instantly identify which ones are approaching the typical timing windows for a sale or recap.
Fully integrated into Dakota Marketplace, this dataset enables deal sourcers, investor relations teams, and allocators to anticipate transactions, build targeted outreach lists, and stay ahead of market announcements, every single day.
To explore more companies likely to transact, book a demo of Dakota Marketplace!
